ReBuilder Medical Technologies, Inc.’s Dr. Phillips to Speak to Ohio Investment Group
CHARLES TOWN, W.Va., Aug. 31 /PRNewswire-FirstCall/ — ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that its CEO David B. Phillips, Ph.D. will speak to a group of 20 physicians representing an investment group seeking to purchase the rights to distribute the company’s products in the state of Ohio.
Physicians all over the U.S. are now using the ReBuilder as their first choice for the treatment of leg pain. Many of them are not registered with Medicare so that they can provide the ReBuilder to their patients with little or no out of pocket cost to the patient.
“I am pleased to help them understand the value of the ReBuilder in practice building,” said David Phillips, Ph.D. CEO, “by integrating neuropathy patients into their practices, they can expect to increase their personal income while providing a valuable service to their community”.
Additionally, Dr. Phillips reports: “A Physician who expands his practice to include neuropathy and peripheral artery disease patients can sometimes see a revenue increase in excess of $200,000 per year.”
Finally, Dr. Phillips told reporters today: “This agreement includes an initial purchase of $100,000 in immediate product.”
Inquiries can be made at www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc.